Attys Get $2.5M In $7.5M Preterm-Birth Drug Settlement

By Mike Curley · January 28, 2026, 6:09 PM EST

A New Jersey federal judge has given final approval to a $7.5 million settlement to end claims that AMAG Pharmaceuticals Inc. knew its preterm-birth prevention drug Makena was ineffective when it...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

MAHER v. AMAG PHARMACEUTICALS, INC.

Case Number

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

January 03, 2020

Recent Articles By Mike

April 02, 2026
NJ Doctor Can't Scrub Suspension For Lax Recordkeeping
April 02, 2026
Ex-IU Basketball Players Filed Sex Abuse Suit Too Late
March 18, 2026
FDA Can't 'Refuse To File' Tobacco Applications, Suit Says
March 17, 2026
9th Circ. Says Idaho Doc Must Face Wash. Fatal Overdose Suit
March 17, 2026
Apple Can't Shake Most PFAS Claims In Smartwatch Suit
March 12, 2026
Idaho Says Director Immune In THC Child Abuse Registry Suit
February 27, 2026
Minn. State Sens. Introduce Medical Psilocybin Bill
February 20, 2026
Lack Of Standing Dooms GardaWorld Health Fees Suit
February 17, 2026
Conn. Judge Says Attys 'Unprepared' At Pretrial Conference
January 06, 2026
Teva Gets Claims Trimmed Ahead Of IUD MDL Bellwether Trial